Nina Warken
Coverage of Nina Warken in the Nexus archive.
- Linnemann wird offenbar neuer Gesundheitsminister
Carsten Linnemann wird voraussichtlich neuer Bundesgesundheitsminister, Nina Warken wechselt in das Kanzleramt. Der Kabinettsumbau folgt dem Rücktritt von Jens Spahn nach Kritik an seiner Nutzung einer Leihmutterschaft in den USA. Linnemann, der zuvor den Posten des Wirtschaftsministers abgelehnt hatte, ist seit 2009 Bundestagsabgeordneter.
- Gesundheitsreform: Merz’ letzter Stresstest vor der Sommerpause
The Bundestag votes on the GKV-Sparpaket health reform package as the constitutional court rejects emergency applications against its rushed legislative process. Health Minister Nina Warken defends the timeline, while CSU leader Klaus Holetschek calls for financial adjustments for hospitals and a 'Germany Bonus' for the pharmaceutical industry. Germany also announces a defense deal to purchase Tomahawk missiles from the U.S. for deterrence against Russia.
- STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
Eli Lilly is reducing its $2.67 billion investment in Germany's weight-loss syringe production due to new cost-cutting laws, and Boehringer Ingelheim is cutting $1 billion in German investments amid sector uncertainty. U.S. FDA Acting Commissioner Kyle Diamantas is engaging rare disease groups to address concerns raised by his predecessor's policies.